Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2018. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3691872015 | Dried aluminium hydroxide gel 44 mg/mL and magnesium hydroxide 39 mg/mL oral suspension | en | Synonym | Active | Only initial character case insensitive | SNOMED CT core module |
| 3691874019 | Dried aluminum hydroxide gel 44 mg/mL and magnesium hydroxide 39 mg/mL oral suspension | en | Synonym | Active | Only initial character case insensitive | SNOMED CT core module |
| 3782357013 | Product containing precisely dried aluminium hydroxide gel 44 milligram/1 milliliter and magnesium hydroxide 39 milligram/1 milliliter conventional release oral suspension (clinical drug) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| 46593001000001112 | Co-magaldrox 195mg/220mg/5ml oral suspension sugar free | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom Edition module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely dried aluminium hydroxide gel 44 milligram/1 milliliter and magnesium hydroxide 39 milligram/1 milliliter conventional release oral suspension (clinical drug) | Is a | Co-magaldrox product | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely dried aluminium hydroxide gel 44 milligram/1 milliliter and magnesium hydroxide 39 milligram/1 milliliter conventional release oral suspension (clinical drug) | Has active ingredient | Antacid | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely dried aluminium hydroxide gel 44 milligram/1 milliliter and magnesium hydroxide 39 milligram/1 milliliter conventional release oral suspension (clinical drug) | Has active ingredient | Aluminium | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely dried aluminium hydroxide gel 44 milligram/1 milliliter and magnesium hydroxide 39 milligram/1 milliliter conventional release oral suspension (clinical drug) | Has active ingredient | Magnesium | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely dried aluminium hydroxide gel 44 milligram/1 milliliter and magnesium hydroxide 39 milligram/1 milliliter conventional release oral suspension (clinical drug) | Has manufactured dose form | Conventional release oral suspension | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely dried aluminium hydroxide gel 44 milligram/1 milliliter and magnesium hydroxide 39 milligram/1 milliliter conventional release oral suspension (clinical drug) | Is a | Product containing aluminium hydroxide and magnesium hydroxide | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely dried aluminium hydroxide gel 44 milligram/1 milliliter and magnesium hydroxide 39 milligram/1 milliliter conventional release oral suspension (clinical drug) | Has active ingredient | Trace element supplementation | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely dried aluminium hydroxide gel 44 milligram/1 milliliter and magnesium hydroxide 39 milligram/1 milliliter conventional release oral suspension (clinical drug) | Has active ingredient | Magnesium-based antacid | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely dried aluminium hydroxide gel 44 milligram/1 milliliter and magnesium hydroxide 39 milligram/1 milliliter conventional release oral suspension (clinical drug) | Has active ingredient | Magnesium hydroxide | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely dried aluminium hydroxide gel 44 milligram/1 milliliter and magnesium hydroxide 39 milligram/1 milliliter conventional release oral suspension (clinical drug) | Has active ingredient | Aluminium hydroxide | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely dried aluminium hydroxide gel 44 milligram/1 milliliter and magnesium hydroxide 39 milligram/1 milliliter conventional release oral suspension (clinical drug) | Has active ingredient | Laxative | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely dried aluminium hydroxide gel 44 milligram/1 milliliter and magnesium hydroxide 39 milligram/1 milliliter conventional release oral suspension (clinical drug) | Is a | Product manufactured as oral dose form | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely dried aluminium hydroxide gel 44 milligram/1 milliliter and magnesium hydroxide 39 milligram/1 milliliter conventional release oral suspension (clinical drug) | Is a | Product containing aluminium hydroxide and magnesium hydroxide in oral dose form (medicinal product form) | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely dried aluminium hydroxide gel 44 milligram/1 milliliter and magnesium hydroxide 39 milligram/1 milliliter conventional release oral suspension (clinical drug) | Has concentration strength denominator unit | Milliliter | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely dried aluminium hydroxide gel 44 milligram/1 milliliter and magnesium hydroxide 39 milligram/1 milliliter conventional release oral suspension (clinical drug) | Count of base of active ingredient | 2 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely dried aluminium hydroxide gel 44 milligram/1 milliliter and magnesium hydroxide 39 milligram/1 milliliter conventional release oral suspension (clinical drug) | Has concentration strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely dried aluminium hydroxide gel 44 milligram/1 milliliter and magnesium hydroxide 39 milligram/1 milliliter conventional release oral suspension (clinical drug) | Has concentration strength denominator unit | Milliliter | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely dried aluminium hydroxide gel 44 milligram/1 milliliter and magnesium hydroxide 39 milligram/1 milliliter conventional release oral suspension (clinical drug) | Has concentration strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely dried aluminium hydroxide gel 44 milligram/1 milliliter and magnesium hydroxide 39 milligram/1 milliliter conventional release oral suspension (clinical drug) | Has concentration strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely dried aluminium hydroxide gel 44 milligram/1 milliliter and magnesium hydroxide 39 milligram/1 milliliter conventional release oral suspension (clinical drug) | Has concentration strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely dried aluminium hydroxide gel 44 milligram/1 milliliter and magnesium hydroxide 39 milligram/1 milliliter conventional release oral suspension (clinical drug) | Has basis of strength substance | Dried aluminium hydroxide gel | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely dried aluminium hydroxide gel 44 milligram/1 milliliter and magnesium hydroxide 39 milligram/1 milliliter conventional release oral suspension (clinical drug) | Has precise active ingredient | Magnesium hydroxide | false | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely dried aluminium hydroxide gel 44 milligram/1 milliliter and magnesium hydroxide 39 milligram/1 milliliter conventional release oral suspension (clinical drug) | Has concentration strength numerator value | 39 | false | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely dried aluminium hydroxide gel 44 milligram/1 milliliter and magnesium hydroxide 39 milligram/1 milliliter conventional release oral suspension (clinical drug) | Has concentration strength numerator value | 44 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely dried aluminium hydroxide gel 44 milligram/1 milliliter and magnesium hydroxide 39 milligram/1 milliliter conventional release oral suspension (clinical drug) | Has basis of strength substance | Magnesium hydroxide | false | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely dried aluminium hydroxide gel 44 milligram/1 milliliter and magnesium hydroxide 39 milligram/1 milliliter conventional release oral suspension (clinical drug) | Has precise active ingredient | Dried aluminium hydroxide gel | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely dried aluminium hydroxide gel 44 milligram/1 milliliter and magnesium hydroxide 39 milligram/1 milliliter conventional release oral suspension (clinical drug) | Plays role | Laxative therapeutic role | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely dried aluminium hydroxide gel 44 milligram/1 milliliter and magnesium hydroxide 39 milligram/1 milliliter conventional release oral suspension (clinical drug) | Is a | Product containing only dried aluminium hydroxide gel and magnesium hydroxide in oral dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely dried aluminium hydroxide gel 44 milligram/1 milliliter and magnesium hydroxide 39 milligram/1 milliliter conventional release oral suspension (clinical drug) | Has basis of strength substance | Dried aluminium hydroxide gel | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely dried aluminium hydroxide gel 44 milligram/1 milliliter and magnesium hydroxide 39 milligram/1 milliliter conventional release oral suspension (clinical drug) | Has basis of strength substance | Magnesium hydroxide | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely dried aluminium hydroxide gel 44 milligram/1 milliliter and magnesium hydroxide 39 milligram/1 milliliter conventional release oral suspension (clinical drug) | Has precise active ingredient | Magnesium hydroxide | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely dried aluminium hydroxide gel 44 milligram/1 milliliter and magnesium hydroxide 39 milligram/1 milliliter conventional release oral suspension (clinical drug) | Has precise active ingredient | Dried aluminium hydroxide gel | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely dried aluminium hydroxide gel 44 milligram/1 milliliter and magnesium hydroxide 39 milligram/1 milliliter conventional release oral suspension (clinical drug) | Is a | Co-magaldrox | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely dried aluminium hydroxide gel 44 milligram/1 milliliter and magnesium hydroxide 39 milligram/1 milliliter conventional release oral suspension (clinical drug) | Has active ingredient | Aluminium hydroxide | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely dried aluminium hydroxide gel 44 milligram/1 milliliter and magnesium hydroxide 39 milligram/1 milliliter conventional release oral suspension (clinical drug) | Has active ingredient | Magnesium hydroxide | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely dried aluminium hydroxide gel 44 milligram/1 milliliter and magnesium hydroxide 39 milligram/1 milliliter conventional release oral suspension (clinical drug) | Count of base of active ingredient | 2 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely dried aluminium hydroxide gel 44 milligram/1 milliliter and magnesium hydroxide 39 milligram/1 milliliter conventional release oral suspension (clinical drug) | Has manufactured dose form | Conventional release oral suspension | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely dried aluminium hydroxide gel 44 milligram/1 milliliter and magnesium hydroxide 39 milligram/1 milliliter conventional release oral suspension (clinical drug) | Has NHS dm+d (dictionary of medicines and devices) controlled drug category | Controlled drug category No Controlled Drug Status | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely dried aluminium hydroxide gel 44 milligram/1 milliliter and magnesium hydroxide 39 milligram/1 milliliter conventional release oral suspension (clinical drug) | Has NHS dm+d (dictionary of medicines and devices) dose form indicator | Discrete dose form indicator | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely dried aluminium hydroxide gel 44 milligram/1 milliliter and magnesium hydroxide 39 milligram/1 milliliter conventional release oral suspension (clinical drug) | Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route | suspension.oral ontology form and route | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely dried aluminium hydroxide gel 44 milligram/1 milliliter and magnesium hydroxide 39 milligram/1 milliliter conventional release oral suspension (clinical drug) | Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration | Oral route | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely dried aluminium hydroxide gel 44 milligram/1 milliliter and magnesium hydroxide 39 milligram/1 milliliter conventional release oral suspension (clinical drug) | Has manufactured dose form | Oral dose form | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely dried aluminium hydroxide gel 44 milligram/1 milliliter and magnesium hydroxide 39 milligram/1 milliliter conventional release oral suspension (clinical drug) | Has active ingredient | Magnesium hydrate | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely dried aluminium hydroxide gel 44 milligram/1 milliliter and magnesium hydroxide 39 milligram/1 milliliter conventional release oral suspension (clinical drug) | Has active ingredient | Aluminium hydroxide gel dried | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely dried aluminium hydroxide gel 44 milligram/1 milliliter and magnesium hydroxide 39 milligram/1 milliliter conventional release oral suspension (clinical drug) | Has manufactured dose form | Conventional release oral suspension | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely dried aluminium hydroxide gel 44 milligram/1 milliliter and magnesium hydroxide 39 milligram/1 milliliter conventional release oral suspension (clinical drug) | Count of base of active ingredient | 2 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely dried aluminium hydroxide gel 44 milligram/1 milliliter and magnesium hydroxide 39 milligram/1 milliliter conventional release oral suspension (clinical drug) | Has NHS dm+d (dictionary of medicines and devices) freeness indicator | Sugar free | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely dried aluminium hydroxide gel 44 milligram/1 milliliter and magnesium hydroxide 39 milligram/1 milliliter conventional release oral suspension (clinical drug) | Count of base of active ingredient | 2 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely dried aluminium hydroxide gel 44 milligram/1 milliliter and magnesium hydroxide 39 milligram/1 milliliter conventional release oral suspension (clinical drug) | Has manufactured dose form | Conventional release oral suspension | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely dried aluminium hydroxide gel 44 milligram/1 milliliter and magnesium hydroxide 39 milligram/1 milliliter conventional release oral suspension (clinical drug) | Count of base of active ingredient | 2 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely dried aluminium hydroxide gel 44 milligram/1 milliliter and magnesium hydroxide 39 milligram/1 milliliter conventional release oral suspension (clinical drug) | Has manufactured dose form | Oral suspension | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely dried aluminium hydroxide gel 44 milligram/1 milliliter and magnesium hydroxide 39 milligram/1 milliliter conventional release oral suspension (clinical drug) | VMP prescribing status (attribute) | VMP valid as a prescribable product | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely dried aluminium hydroxide gel 44 milligram/1 milliliter and magnesium hydroxide 39 milligram/1 milliliter conventional release oral suspension (clinical drug) | VMP non-availability indicator | Available | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely dried aluminium hydroxide gel 44 milligram/1 milliliter and magnesium hydroxide 39 milligram/1 milliliter conventional release oral suspension (clinical drug) | Has specific active ingredient | Aluminium hydroxide gel dried | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely dried aluminium hydroxide gel 44 milligram/1 milliliter and magnesium hydroxide 39 milligram/1 milliliter conventional release oral suspension (clinical drug) | Has specific active ingredient | Magnesium hydroxide | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely dried aluminium hydroxide gel 44 milligram/1 milliliter and magnesium hydroxide 39 milligram/1 milliliter conventional release oral suspension (clinical drug) | Has dispensed dose form | Conventional release oral suspension | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely dried aluminium hydroxide gel 44 milligram/1 milliliter and magnesium hydroxide 39 milligram/1 milliliter conventional release oral suspension (clinical drug) | Is a | Virtual medicinal product | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Co-magaldrox 220mg/195mg/5mL oral suspension - product | Is a | False | Product containing precisely dried aluminium hydroxide gel 44 milligram/1 milliliter and magnesium hydroxide 39 milligram/1 milliliter conventional release oral suspension (clinical drug) | Inferred relationship | Existential restriction modifier | |
| Mucogel oral suspension (Rosemont Pharmaceuticals Ltd) | Is a | True | Product containing precisely dried aluminium hydroxide gel 44 milligram/1 milliliter and magnesium hydroxide 39 milligram/1 milliliter conventional release oral suspension (clinical drug) | Inferred relationship | Existential restriction modifier | |
| Maalox oral suspension (Aventis Pharma) | Is a | True | Product containing precisely dried aluminium hydroxide gel 44 milligram/1 milliliter and magnesium hydroxide 39 milligram/1 milliliter conventional release oral suspension (clinical drug) | Inferred relationship | Existential restriction modifier | |
| Co-magaldrox 195mg/220mg/5ml oral suspension sugar free 500 ml | Is pack of | False | Product containing precisely dried aluminium hydroxide gel 44 milligram/1 milliliter and magnesium hydroxide 39 milligram/1 milliliter conventional release oral suspension (clinical drug) | Inferred relationship | Existential restriction modifier | |
| Co-magaldrox 195mg/220mg/5ml oral suspension sugar free 500 ml | Has VMP | True | Product containing precisely dried aluminium hydroxide gel 44 milligram/1 milliliter and magnesium hydroxide 39 milligram/1 milliliter conventional release oral suspension (clinical drug) | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR